- March 27, 2017 | BY
All models are wrong, but some are useful: Novel ways of using MDX mice to study a devastating childhood disease
- March 24, 2017 | BY
Insights into Alzheimer’s, a look into the middle-aged white mortality rate, and is a cancer diagnosis just a sign of bad luck?
- March 23, 2017 | BY
New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.
- March 20, 2017 | BY
Improvements in humanized mouse models for cancer are helping us more accurately recapitulate the in vivo function of human cells and tissues.
- March 17, 2017 | BY
Optimizing your March Madness bracket, good vs. bad bacteria and restoring sight one nanostep at a time.
- March 15, 2017 | BY
Scientists study the immunotherapy strategy in brain cancers, plus a real pissing match in the mouse cage. Day Three from SOT.
- March 14, 2017 | BY
It’s been 11 years since the EU passed legislation requiring companies to register their use of chemicals by 2018. How’s that going? Day Two of our SOT coverage.
- March 13, 2017 | BY
Molecular imaging has long been a major player in clinical medicine. What about its utility in earlier phases of preclinical drug development?
- March 10, 2017 | BY
Is CRISPR legit, Congress makes a significant move and the FDA tries to decide what makes healthy food “healthy.”
- March 8, 2017 | BY
A period list of methods, tools and people driving research and development. Our scientists present nine tools helping to advance safety assessment. (The list is not ranked.)